Interesting ImagesClinical Utility of 68Ga–Prostate-Specific Membrane Antigen PET/CT Scan on Postoperative Assessment of Juvenile Nasal AngiofibromaThakar, Alok MS*; Sakthivel, Pirabu MS*; Prashanth, Arun MD†; Kumar, Rakesh MS*; Sharma, Suresh Chandra MS*; Kumar, Rakesh MD†Author Information From the Departments of *Otorhinolaryngology and Head and Neck Surgery †Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India. Received for publication May 17, 2019; revision accepted June 5, 2019. Conflicts of interest and sources of funding: none declared. Correspondence to: Rakesh Kumar, MS, Division of Diagnostic Nuclear Medicine, Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi 110029, India. E-mail: email@example.com. Online date: July 25, 2019 Clinical Nuclear Medicine: February 2020 - Volume 45 - Issue 2 - p e83-e84 doi: 10.1097/RLU.0000000000002745 Buy Metrics Abstract Prostate-specific membrane antigen (PSMA) is expressed on the endothelial cells of tumor-associated neovasculature of various nonprostatic benign and malignant neoplasms. Positive uptake on PET/CT imaging with 68Ga-labeled PSMA is noted in a patient with juvenile nasal angiofibroma, and the same is noted to be absent following complete surgical excision. 68Ga-PSMA PET/CT may be a useful tool for juvenile nasal angiofibroma recurrence identification and in differentiating recurrence from surgical site reparative tissue. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.